BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15247247)

  • 1. Phosphorylation of Sp1 by cyclin-dependent kinase 2 modulates the role of Sp1 in CTP:phosphocholine cytidylyltransferase alpha regulation during the S phase of the cell cycle.
    Banchio C; Schang LM; Vance DE
    J Biol Chem; 2004 Sep; 279(38):40220-6. PubMed ID: 15247247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of CTP:phosphocholine cytidylyltransferase alpha expression during the S phase of the cell cycle is mediated by the transcription factor Sp1.
    Banchio C; Schang LM; Vance DE
    J Biol Chem; 2003 Aug; 278(34):32457-64. PubMed ID: 12794070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic Ha-Ras transformation modulates the transcription of the CTP:phosphocholine cytidylyltransferase alpha gene via p42/44MAPK and transcription factor Sp3.
    Bakovic M; Waite K; Vance DE
    J Biol Chem; 2003 Apr; 278(17):14753-61. PubMed ID: 12584202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sp1 is a co-activator with Ets-1, and Net is an important repressor of the transcription of CTP:phosphocholine cytidylyltransferase alpha.
    Sugimoto H; Okamura K; Sugimoto S; Satou M; Hattori T; Vance DE; Izumi T
    J Biol Chem; 2005 Dec; 280(49):40857-66. PubMed ID: 16157598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional significance of Sp1, Sp2, and Sp3 transcription factors in regulation of the murine CTP:phosphocholine cytidylyltransferase alpha promoter.
    Bakovic M; Waite KA; Vance DE
    J Lipid Res; 2000 Apr; 41(4):583-94. PubMed ID: 10744779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of histone deacetylase in the expression of CTP:phosphocholine cytidylyltransferase alpha.
    Banchio C; Lingrell S; Vance DE
    J Biol Chem; 2006 Apr; 281(15):10010-5. PubMed ID: 16484221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Ets-1 as an important transcriptional activator of CTP:phosphocholine cytidylyltransferase alpha in COS-7 cells and co-activation with transcriptional enhancer factor-4.
    Sugimoto H; Sugimoto S; Tatei K; Obinata H; Bakovic M; Izumi T; Vance DE
    J Biol Chem; 2003 May; 278(22):19716-22. PubMed ID: 12642588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription of the CTP:phosphocholine cytidylyltransferase alpha gene is enhanced during the S phase of the cell cycle.
    Golfman LS; Bakovic M; Vance DE
    J Biol Chem; 2001 Nov; 276(47):43688-92. PubMed ID: 11557772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific interaction between E2F1 and Sp1 regulates the expression of murine CTP:phosphocholine cytidylyltransferase alpha during the S phase.
    Elena C; Banchio C
    Biochim Biophys Acta; 2010 Apr; 1801(4):537-46. PubMed ID: 20096375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp-1 binds promoter elements that are regulated by retinoblastoma and regulate CTP:phosphocholine cytidylyltransferase-alpha transcription.
    Banchio C; Lingrell S; Vance DE
    J Biol Chem; 2007 May; 282(20):14827-35. PubMed ID: 17384411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Sp1 activity by a cyclin A/CDK complex.
    Haidweger E; Novy M; Rotheneder H
    J Mol Biol; 2001 Feb; 306(2):201-12. PubMed ID: 11237594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdc2-cyclin E complexes regulate the G1/S phase transition.
    Aleem E; Kiyokawa H; Kaldis P
    Nat Cell Biol; 2005 Aug; 7(8):831-6. PubMed ID: 16007079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTP:phosphocholine cytidylyltransferase, a new sterol- and SREBP-responsive gene.
    Kast HR; Nguyen CM; Anisfeld AM; Ericsson J; Edwards PA
    J Lipid Res; 2001 Aug; 42(8):1266-72. PubMed ID: 11483628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclin D1 overexpression on G1 progression-related events.
    Imoto M; Doki Y; Jiang W; Han EK; Weinstein IB
    Exp Cell Res; 1997 Oct; 236(1):173-80. PubMed ID: 9344597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle progression without cyclin E/CDK2: breaking down the walls of dogma.
    Gladden AB; Diehl JA
    Cancer Cell; 2003 Sep; 4(3):160-2. PubMed ID: 14522248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
    Alessi F; Quarta S; Savio M; Riva F; Rossi L; Stivala LA; Scovassi AI; Meijer L; Prosperi E
    Exp Cell Res; 1998 Nov; 245(1):8-18. PubMed ID: 9828096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term 17alpha-ethinyl estradiol treatment decreases cyclin E and cdk2 expression, reduces cdk2 kinase activity and inhibits S phase entry in regenerating rat liver.
    Koroxenidou L; Ohlson LC; Porsch Hällström I
    J Hepatol; 2005 Sep; 43(3):478-84. PubMed ID: 16019103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic CTP:phosphocholine cytidylyltransferase-alpha is a critical predictor of plasma high density lipoprotein and very low density lipoprotein.
    Jacobs RL; Lingrell S; Zhao Y; Francis GA; Vance DE
    J Biol Chem; 2008 Jan; 283(4):2147-55. PubMed ID: 18042552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.